Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Introducing the SAGE study: a multimodal protocol for testing a GABAergic mechanism of age-related episodic memory impairment across the sexes.

BMJ neurology open·2026
Same author

Personalized Blood Pressure Targeting After Endovascular Therapy for Acute Ischemic Stroke: A Randomized Clinical Trial.

JAMA neurology·2026
Same author

Genome-wide association study links COL6A6 and PIK3R4 to delayed cerebral ischaemia.

Brain : a journal of neurology·2026
Same author

CSF Biomarker Profile of Cerebral Amyloid Angiopathy: Diagnostic Performance and Imaging Correlates in a Hospital-Based Neurology Cohort.

European journal of neurology·2026
Same author

European Stroke Organisation (ESO), European Association of Neurosurgical Societies (EANS) and European Society for Minimally Invasive Neurological Therapy (ESMINT) guideline on aneurysmal subarachnoid haemorrhage.

European stroke journal·2026
Same author

Five-Year Efficacy and Safety of the FRED Flow-Diverting Stent for Intracranial Aneurysms: Results From a Prospective Cohort.

Stroke (Hoboken, N.J.)·2026

Related Experiment Video

Updated: Aug 10, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.3K

Machine Learning Approximations to Predict Epigenetic Age Acceleration in Stroke Patients.

Isabel Fernández-Pérez1, Joan Jiménez-Balado1, Uxue Lazcano2

  • 1Neurovascular Research Group, Department of Neurology, IMIM-Hospital del Mar (Institut Hospital del Mar d'Investigacions Mèdiques), 08003 Barcelona, Spain.

International Journal of Molecular Sciences
|February 11, 2023
PubMed
Summary

Environmental and lifestyle factors influence biological aging, but cannot fully predict age acceleration in cerebrovascular disease patients. Machine learning models showed modest predictive power for age acceleration.

Keywords:
agingepigenetic clockmachine learningstrokevascular risk factors

More Related Videos

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.8K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.0K

Related Experiment Videos

Last Updated: Aug 10, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.3K
Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.8K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.0K

Area of Science:

  • Epigenetics and Aging
  • Computational Biology
  • Vascular Medicine

Background:

  • Age acceleration (Age-A) is a predictor of health outcomes, estimated via DNA methylation.
  • Age-A is influenced by environmental, lifestyle, and vascular risk factors (VRF).

Purpose of the Study:

  • To quantify the contribution of easily measurable factors to Age-A in cerebrovascular disease (CVD) patients.
  • To develop an accessible model for predicting Age-A using machine learning (ML).

Main Methods:

  • Analyzed a CVD cohort of 952 patients, assessing VRF, lifestyle, and target organ damage.
  • Estimated Age-A using Hannum's epigenetic clock.
  • Trained six models (linear regression, elastic net, K-Nearest Neighbors, random forest, support vector machine, multilayer perceptron) to predict Age-A.

Main Results:

  • Elastic Net (EN) and Multilayer Perceptron (MLP) models demonstrated the best performance.
  • Predictive capability was modest, with R-squared values of 0.358 for EN and 0.378 for MLP.
  • Identified factors influenced Age-A, but did not explain the majority of its variability.

Conclusions:

  • Environmental and lifestyle factors, along with VRF, contribute to Age-A in CVD patients.
  • Current easily measurable factors are insufficient to fully explain Age-A variability.
  • Further research is needed to identify additional predictors for more accurate Age-A modeling.